lendix

becomes

logo
Learn moreContinue to october.eu

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more

< all projects

Ariostea M.H.S. #2

presented by October Italy

€1,100,000

5.6%

48 months

B

If I had lent to this project?

lent to this project, means…

paid back in total

taxes not included

Create your account

Warning Lending money to SMEs presents a risk of capital loss and requires your savings to be immobilised.

location

Location

Brescia, Italy

activity

Activity

Marketing surveys & consulting

Presentation of the company

Created in 2012, Ariostea M.H.S. S.r.l. is active in the machine manufacturing sector. The company, managed by Arturo Moreschi, has 24 employees and is based in Brescia (Italy).

Arturo Moreschi, managing director, has overall 20 years of professional experience in the sector.

The company’s main activity is the engineering, design, construction and installation of systems for the transport and storage of raw materials for the chemical and plastics industry.

The company works with business customers spread all over the world, more than 75% of turnover is made outside Europe.

The Company works with a consolidated basis of customer.

Minority shareholder of the Company is Zzen Real Estate Italy S. r. l. , italian branch of Zzen group belonging to the tycoon Vic De Zen.

Project Description

The company requests 1 100 000 € to finance part of the acquisition of the real estate property where the activity is done. This project will be realized next month.

As a reminder, the October lending community supported the Company in 2018 with 750 000 € to finance the purchase of a new machinery. The loan repayment is in line with the initial schedule with non incidents reported.

At least 40% of the risk of this loan is covered by a guarantee from the Republic of Italy via the ‘Fondo di Garanzia PMI’.

The amount offered on the platform is limited to 539 000 €, which is in line with the regulatory limits.